Current through Register Vol. 63, No. 8, August 1, 2024
Section 836-200-0625 - Prohibited Conduct for LicenseesA licensee may not:
(1) Engage in any deceptive or misleading marketing of a pharmaceutical product, including knowingly concealing, suppressing, omitting, misrepresenting, or misstating material facts concerning or related to a pharmaceutical product;(2) Use a title or designation that could reasonably lead a health care provider or an employee of a health care provider to believe that the licensee is a health care provider if the licensee is not licensed as a health care provider or otherwise authorized to provide health care services; (3) Attend an examination of a patient without the patient's consent; or(4) Make or file, or cause to be made or filed, to or with the director of the Department of Consumer and Business Services, any statement, report or document which is known to be false in any material respect or matter.Or. Admin. R. 836-200-0625
ID 13-2021, temporary adopt filed 12/20/2021, effective 12/20/2021 through 06/17/2022; ID 2-2022, adopt filed 06/16/2022, effective 6/17/2022Statutory/Other Authority: ORS 731.244 & Or Laws 2021, ch 593
Statutes/Other Implemented: Or Laws 2021, ch 593